Cardiology

At the American Association of Clinical Endocrinology 2025 Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving scope of GLP-1–based therapies, highlighting emerging molecules,...

Excess visceral fat, rather than BMI alone, is a key driver of cardiovascular risk in people with HIV receiving antiretroviral therapy. The study authors presented their findings at the Conference on...

Anticoagulation after trauma reduces the risk of stroke and transient ischemic attacks without significantly increasing bleeding or readmissions, according to the results of a study presented at the Society...

Preoperative diastolic dysfunction significantly elevates the risk of major adverse cardiac events and long-term mortality in patients undergoing hip fracture surgery, according to a retrospective cohort...

This prognostic cohort study aimed to develop and validate AIRE-HTN, an AI-ECG model, to predict incident hypertension and stratify patients at risk for hypertension-related adverse outcomes.

A study that was presented at the American College of Cardiology's 74th Annual Scientific Session & Expo in Chicago, IL found that midlife women using a mobile health app had higher engagement and...

A new study reveals high discontinuation rates of semaglutide among older adults with diabetes in the US and Japan, potentially limiting its cardioprotective benefits.

Despite advancements in guideline-directed therapy, heart failure readmissions remain high. At the American College of Physicians Internal Medicine Meeting 2025, Shudhanshu Alishetti, MD, outlined how...

In a large, matched-cohort study, patients with coronary artery disease receiving colchicine plus an SGLT2 inhibitor had significantly lower risks of mortality, MACE, ischemic stroke, and atrial...

A study presented at the American College of Cardiology's 74th Annual Scientific Session found that GLP-1RA use in patients with psoriasis was linked to a lower incidence of major adverse cardiovascular...